[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-345875-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-345875-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","preservation-and-clonal-behavior-of-extrachromosomal-dna-in-patient-derived-xenograft-models-of-childhood-cancers","Preservation and clonal behavior of extrachromosomal DNA in patient-derived xenograft models of childhood cancers","","Extrachromosomal DNA (ecDNA) is a structural variant associated with poor prognosis in pediatric cancers. Patient-derived xenograft (PDX) models are widely used because they may mirror the molecular traits and intratumoral heterogeneity of patient tumors, yet ecDNA evolutionary behavior during PDX establishment remains unclear. This study evaluates how faithfully PDXs represent ecDNA by comparing ecDNA sequence composition and copy-number conservation across pediatric solid cancers, using matched primary and PDX samples.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/preservation-and-clonal-behavior-of-extrachromosomal-dna-in-patient-derived-xenograft-models-of-childhood-cancers/345875/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/preservation-and-clonal-behavior-of-extrachromosomal-dna-in-patient-derived-xenograft-models-of-childhood-cancers/345875.png","ImageObject",300,407,{"name":42,"@type":43},"Quinn","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-27","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",10,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What question does the study address about ecDNA in PDX models?","Question",{"text":63,"@type":64},"It tests whether PDX models preserve and recapitulate the ecDNA landscape from the primary pediatric tumors they are derived from.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How were ecDNA sequences and copy numbers evaluated in this research?",{"text":68,"@type":64},"The study used AmpliconArchitect to analyze whole-genome sequencing from 338 PDX models and 127 matched primary tumors, comparing ecDNA status, sequence, copy number, and associated genes.",{"name":70,"@type":61,"acceptedAnswer":71},"What were the main findings regarding ecDNA fidelity between PDXs and primary tumors?",{"text":72,"@type":64},"Most PDX models retained ecDNA status relative to the primary tumors, oncogene amplifications were largely recapitulated, and rare ecDNA-positive primary cells preferentially drove PDX tumor development.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},345875,1790195131,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":55,"slug":125},"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":109,"preview_page_count":33,"preview_urls":145},962075114765,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","Kenkre etal. Genome Medicine (2026) 18:110  \n[https://doi.org/10.1186/s13073-026-01676-0](https://doi.org/10.1186/s13073-026-01676-0)  \nGenome Medicine  \nRESEARCH Open Access  \nPreservation and clonal behavior    \nof extrachromosomal DNA in patient-derived xenograft models of childhood cancers  \nRishaan Kenkre1, Owen S. Chapman 1,2, Eugene Yui-Ching Chow1, Jens Luebeck3, Yan Yuen Lo 1, Megan Paul4,5, Wenshu Zhang6, Jill Mesirov7,8, Vineet Bafna3,8,9, Kevin Yip1, Jon D. Larson 1, Robert J. Wechsler-Reya 10 and Lukas Chavez1,11,12*  \nAbstract  \nBackground Extrachromosomal DNA (ecDNA) is a structural variant linked to poor prognosis in pediatric cancers. Patient-derived xenograft (PDX) models are crucial tools for cancer research, as they are believed to recapitulate the molecular features and intratumoral heterogeneity in patient tumors. However, ecDNA demonstrates unique evolutionary dynamics under selective pressure, and its behavior during PDX development remains largely uncharacterized. This study investigates the fidelity of PDX models in representing ecDNA from primary tumors. By analyzing ecDNA sequence composition and copy number conservation across pediatric solid cancers, we assess how well PDX models recapitulate the ecDNA landscape observed in human tumors.  \nMethods AmpliconArchitect was used to analyze whole-genome sequencing (WGS) of 338 PDX models and  \n127 corresponding primary tumors. ecDNA status, sequence, copy number, and associated genes were compared between PDX models and their matched human tumors. Additionally, multiome RNA and ATAC single-cell sequencing of a PDX tumor enabled comparison of ecDNA intratumoral heterogeneity relative to similar data from the primary tumor.  \nResults ecDNA in PDX models largely recapitulated oncogene amplifications observed in human tumors, with MYCN being the most frequently amplified. ecDNA status remained unchanged for a majority of the PDX models (105/127, 83%) compared to primary tumors, with 20% of previously ecDNA-negative cases acquiring ecDNA during PDX development. Consequently, ecDNA was more prevalent in the PDX models than in their corresponding human tumors (McNemar's test, p = 0 . 00086) . Detailed examination of ecDNA sequences in tumor-PDX pairs showed substantial conservation (67% with > 90% sequence overlap) but variable breakpoint concordance. Singlecell analysis demonstrated that rare ecDNA-positive cells from the primary tumor preferentially drive PDX tumor development.  \nConclusion This study highlights the prevalence, oncogenic content, and conservation of ecDNA in PDX models relative to pediatric patient tumors. We observed that ecDNA frequently recapitulates oncogene amplifications  \n*Correspondence:  \nLukas Chavez [lchavez@sbpdiscovery.org](lchavez@sbpdiscovery.org)  \nFull list of author information is available at the end of the article  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/.)[.](http://creativecommons.org/licenses/by/4.0/.)  \nKenkre et al. Genome Medicine (2026) 18:110 Page 2 of 16  \nfound in human cancers, is generally preserved during PDX establishment, and reflects subtype-spe","cbCaijL1sygtgAWL","https://ap.wps.com/l/cbCaijL1sygtgAWL","pdf",2315563,16,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusion\n## Keywords\n## Background","[{\"question\":\"What question does the study address about ecDNA in PDX models?\",\"answer\":\"It tests whether PDX models preserve and recapitulate the ecDNA landscape from the primary pediatric tumors they are derived from.\"},{\"question\":\"How were ecDNA sequences and copy numbers evaluated in this research?\",\"answer\":\"The study used AmpliconArchitect to analyze whole-genome sequencing from 338 PDX models and 127 matched primary tumors, comparing ecDNA status, sequence, copy number, and associated genes.\"},{\"question\":\"What were the main findings regarding ecDNA fidelity between PDXs and primary tumors?\",\"answer\":\"Most PDX models retained ecDNA status relative to the primary tumors, oncogene amplifications were largely recapitulated, and rare ecDNA-positive primary cells preferentially drove PDX tumor development.\"}]","Preservation and clonal behavior of extrachromosomal DNA in patient-derived xenograft models of childhood cancers | PDF",1790059206,[146,150,154,158],{"page_no":22,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/50fb65b2e6dd8d55842d385659d0f56e.webp",983,1310,{"page_no":26,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d80d7ca97cf0c6059fdedc280d2ef95c.webp",982,1309,{"page_no":30,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6a03d066db9b1d9b328d6f8c31d57ccb.webp",981,1308,{"page_no":33,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/699f707ee46c61f51cc0e33d60ca8b65.webp",980,1306]